Search Within

Antonio Marcilio Padula Omuro

Formats
  1. Meeting Abstract (105)
  2. Journal Article (96)
  3. Book Section (2)
  4. Research Letter (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (92)
  2. GSK Faculty (57)
  3. Radiology, Department of (46)
  4. Human Oncology and Pathogenesis Program (43)
  5. Neuroradiology Service (41)
  6. Epidemiology and Biostatistics (37)

More Groups

People
  1. Lisa De Angelis (81)
  2. Lauren Abrey (41)
  3. Thomas Kaley (38)
  4. Ingo Mellinghoff (36)
  5. Elena Pentsova (33)
  6. Craig Nolan (26)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (2)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (5)

More Years

Publications
  1. Neuro-Oncology (63)
  2. Journal of Clinical Oncology (48)
  3. Journal of Neuro-Oncology (11)
  4. Neurology (8)
  5. Blood (6)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. Oxford University Press (68)
  2. American Society of Clinical Oncology (49)
  3. Springer (17)
  4. Lippincott Williams & Wilkins (11)
  5. Elsevier Inc. (10)
  6. Wiley Blackwell (7)

More Publishers

Results (204)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab effects masking leptomeningeal spread in a patient with recurrent glioblastoma
    Meeting Abstract

    Pentsova, E.; Faivre, G.; Demopoulos, A.; Taillibert, S.; Rosenblum, M.; Omuro, A.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Radiographic patterns of recurrence with pathologic correlation in patients with malignant gliomas treated with bevacizumab (BEV)
    Meeting Abstract

    Kaley, T. J.; Huse, J.; Karimi, S.; Rosenblum, M.; Omuro, A.; Deangelis, L. M.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Bevacizumab in multiply recurrent aggressive meningiomas
    Meeting Abstract

    Nayak, L.; Iwamoto, F. M.; Rudnick, J. D.; Norden, A. D.; Omuro, A.; Kaley, T. J.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Outcome of the oldest old with primary central nervous system lymphoma (PCNSL) at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Welch, M. R.; Omuro, A.; Deangelis, L. M.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Primary central nervous system lymphoma: Is there still a role for radiotherapy?
    Journal Article

    Graber, J. J.; Omuro, A.
    Current Opinion in Neurology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ) and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Beal, K.; Omuro, A.; Karimi, S.; Correa, D.; Chan, T. A.; Deangelis, L. M.; Yamada, Y.; Abrey, L. E.; Gutin, P. H.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy
    Journal Article

    Morris, P. G.; Abrey, L. E.; Reiner, A. S.; Wu, N.; Panageas, K. S.; Seko, B. S.; Deangelis, L. M.; Omuro, A.
    Leukemia and Lymphoma (2011)

    Fulltext@MSK | Save
  • Primary CNS lymphoma in patients younger than 60: Can whole-brain radiotherapy be deferred?
    Journal Article

    Omuro, A.; Taillandier, L.; Chinot, O.; Sierra Del Rio, M.; Carnin, C.; Barrie, M.; Soussain, C.; Tanguy, M. L.; Choquet, S.; Leblond, V.; more...
    Journal of Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
    Journal Article

    Young, R. J.; Gupta, A.; Shah, A. D.; Graber, J. J.; Zhang, Z.; Shi, W.; Holodny, A. I.; Omuro, A. M. P.
    Neurology (2011)

    Fulltext@MSK | Save